Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-13-058946
Filing Date
2013-08-01
Accepted
2013-08-01 16:08:08
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a13-13609_110q.htm 10-Q 1358738
2 EX-10.1 a13-13609_1ex10d1.htm EX-10.1 59816
3 EX-31.1 a13-13609_1ex31d1.htm EX-31.1 11906
4 EX-31.2 a13-13609_1ex31d2.htm EX-31.2 11911
5 EX-32.1 a13-13609_1ex32d1.htm EX-32.1 7801
  Complete submission text file 0001104659-13-058946.txt   16608279

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vphm-20130630.xml EX-101.INS 1546429
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vphm-20130630.xsd EX-101.SCH 100956
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vphm-20130630_cal.xml EX-101.CAL 80578
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vphm-20130630_def.xml EX-101.DEF 527846
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT vphm-20130630_lab.xml EX-101.LAB 1612084
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vphm-20130630_pre.xml EX-101.PRE 862228
Mailing Address 730 STOCKTON DRIVE EXTON PA 19341
Business Address 730 STOCKTON DRIVE EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

EIN.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21699 | Film No.: 131002745
SIC: 2834 Pharmaceutical Preparations